Author

Cecilia Svanberg

Linköping UniversityORCID 0000-0003-3619-5228Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:chromatin & epigenetic regulation· 1 Assay:DNA methylation· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Approach:statistical model· 1

Frequent Co-Authors

Esaki Muthu ShankariD· 2 shared Francis R. HopkinsiD· 2 shared Marie LarssoniD· 2 shared Sofia N. NyströmiD· 2 shared Åsa Nilsdotter‐AugustinssoniD· 1 shared Christopher SjöwalliD· 1 shared Johan NordgreniD· 1 shared Johanna SjöwalliD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 40 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Esaki Muthu ShankarORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologyCellsPeer-reviewedOct 27, 2025

Altered DNA methylation pattern contributes to differential epigenetic immune signaling in the upper respiratory airway of COVID-19 patients

Melissa Govender, Jyotirmoy Das, Francis R. Hopkins…·Marie Larsson

This study identifies altered DNA methylation patterns in the upper respiratory airway of COVID-19 patients, highlighting changes in immune-related genes and potential implications for airway health.

4 citations

humanDNA methylation

𝕏 PostBluesky

ImmunologybioRxivPreprintFeb 17, 2025

HIV-1 derived replication intermediates/oligonucleotides induce a type I IFN-dependent immune suppression via STING activation that can be restored by targeting IFNARI

Cecilia Svanberg, Ravi Prasad Mukku, Özkan Besler…·Marie Larsson

This study shows HIV-1-derived oligonucleotides activate STING and type I IFN signaling in dendritic cells, leading to immune suppression that can be reversed by targeting IFNAR1 with Anifrolumab.

DOI 10.1101/2025.02.17.638698

humanbulk RNA-seq

𝕏 PostBluesky